Work

Faculty of 1000 evaluation for Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a Phase 2 Trial of the Gynecologic Oncology Group.

Cites:
Cited by:
Related to: 10